Revenue
2018
2019
2020
2021
2022
2023
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | £23.52B | £22.45B | £19.15B | £17.70B | £19.29B | £18.43B | — | — |
| Gross profit | £10.21B | £9.48B | £7.70B | £7.10B | £8.00B | £7.53B | £7.37B | £6.23B |
| Research & development | £53.0M | £43.0M | £40.0M | £34.0M | £35.0M | £36.0M | £33.0M | £28.0M |
| Operating expenses | £18.88B | £18.04B | £15.42B | £15.56B | £15.25B | £14.74B | £14.55B | £12.80B |
| Operating income | £4.63B | £4.41B | £3.73B | £2.14B | £4.04B | £3.69B | £3.56B | £2.84B |
| Net income | £3.73B | £3.25B | £2.66B | £1.41B | £3.16B | £3.02B | £2.77B | £2.36B |
| Basic EPSper diluted share | £1.65 | £1.40 | £1.14 | £0.60 | £1.31 | £1.22 | £1.06 | £0.90 |
| Diluted EPSper diluted share | £1.64 | £1.40 | £1.13 | £0.60 | £1.30 | £1.21 | £1.06 | £0.89 |